Fairhurst, C., Martin, F., Watt, I., Bland, M., Doran, T., & Brackenbury, W. J. (2023). Sodium channel-inhibiting drugs and cancer-specific survival: a population-based study of electronic primary care data. Bmj Open, 13, e064376. http://doi.org/10.1136/bmjopen-2022- ...
Antiarrhythmia agents. Omega-3 fatty acids. Ion channels. Torsades de pointes. Issue Date: Oct-2008. ... Ultrafast sodium channel block by dietary fish oil prevents dofetilide-induced ventricular arrhythmias in rabbit hearts. ...
Cardiac glycosides alone or combined with anti-arrhythmia agents?]. Dtsch Med Wochenschr. 1988;113:1867-1871. [PubMed] [DOI] [ ... Post-hoc analysis of arrhythmia burden data demonstrated that amiodarone and class Ic agents demonstrated similar efficacy in ... The Cardiac Arrhythmia Suppression Trial. N Engl J Med. 1991;324:781-788. [PubMed] [DOI] [Cited in This Article: ] [Cited by in ... a new antiarrhythmic agent. Circulation. 1982;65:879-885. [PubMed] [DOI] [Cited in This Article: ] [Cited by in Crossref: 105] ...
Anti-Arrhythmia Agents / therapeutic use* * Cardiopulmonary Resuscitation / methods * Central Nervous System Diseases / ... Anti-Arrhythmia Agents / adverse effects * ...
Anti-Arrhythmia Agents / therapeutic use * Asia / epidemiology * Atrial Fibrillation / classification * Atrial Fibrillation / ...
More precisely, however, it is termed an antimuscarinic agent since it antagonizes the muscarine-like actions of acetylcholine ... For the treatment of poisoning by susceptible organophosphorous nerve agents having cholinesterase activity as well as ... anticholinesterase agents or other parasympathomimetic drugs, and cardiac arrest produced by stimulation of the vagus. Atropine ...
More precisely, however, it is termed an antimuscarinic agent since it antagonizes the muscarine-like actions of acetylcholine ... For the treatment of poisoning by susceptible organophosphorous nerve agents having cholinesterase activity as well as ... anticholinesterase agents or other parasympathomimetic drugs, and cardiac arrest produced by stimulation of the vagus. Atropine ...
Warembourg, H; Ducloux, G (1976). "Clinical study of a new anti-arrhythmia agent: nadoxolol". Lille Med. 21 (4): 386-8. PMID ... Nadoxolol is an antiarrhythmic agent (i.e., a drug for the treatment of irregular heartbeat), chemically related in structure ... Antiarrhythmic agents, 1-Naphthyl compounds, All stub articles, Cardiovascular system drug stubs). ...
Anti-Arrhythmia Agent; Adrenergic Agent; Antihypertensive Agent; Metabolite; Adrenergic beta-Antagonist; Synthetic Compound; ...
A potentially lethal cardiac arrhythmia that is characterized by uncoordinated extremely rapid firing of electrical impulses ( ... Anti-Arrhythmia AgentsIBA 02/17/2009 - "Our purpose was to evaluate the efficacy of antiarrhythmic drugs (AADs) in recurrent ... Drugs and Important Biological Agents (IBA) related to Ventricular Fibrillation: 1. Amiodarone (Amiodarona)FDA LinkGeneric 04/ ... 06/01/1979 - "Several investigations into the prophylactic use of lidocaine to prevent the development of arrhythmias have ...
Education, Medical, Continuing, Atrial Fibrillation/therapy, Stroke/prevention & control, Anti-Arrhythmia Agents, Symptoms in ...
Keywords: Anti-Arrhythmia Agents, Anticoagulants, Aspirin, Atrial Fibrillation, Benzimidazoles, Catheter Ablation, ... Complementary Therapies, Fibrinolytic Agents, Pyrazoles, Risk Factors, Sotalol, Sulfonamides, Thiophenes, Ticlopidine , Back to ... the European Cardiac Arrhythmia Society, the European Heart Rhythm Association, the Society of Thoracic Surgeons, the Asia ... for multiple agents. Instead the guidelines recommend avoiding flecainide, propafenone, sotalol, and dofetilide in patients ...
Pharma Action Anti-Arrhythmia Agents Nippon Yakurigaku Zasshi 1987;89(3):155 erythromycin, zinc acetate drug combination 0 * ... Pharma Action Antifungal Agents Biochim Biophys Acta 1981;664(2):349 ethyl sebacate 110-40-7 *Decanoic Acids. Contact ...
Anti-Arrhythmia Agents 32% * Atrial Fibrillation 24% * Atrial Flutter 34% * Cardiac Arrhythmias 94% ... Dive into the research topics of How to detect and treat arrhythmias in chronic lung disease.. Together they form a unique ...
exp Tachycardia, Supraventricular/ ) OR (exp Anti-Arrhythmia Agents/) OR (narrow complex tachycardia.mp) OR (exp Tachycardia, ... exp Anti-Arrhythmia Agents/) OR (narrow complex tachycardia.mp) OR (exp Tachycardia, Atrioventricular Nodal Reentry/)] OR [( ... Esmolol is an agent to consider when treating haemodinamically stable supraventricular tachycardias amenable to beta-blockade ... The use of ultra-short acting beta-blocking agents in the acute management of supraventricular tachycardias in the ...
Anti-Arrhythmia Agents. Antiarrítmicos. Antiarrítmicos. Antiarythmiques. antiarrítmicos. Voltage-Gated Sodium Channel Blockers ... A class I anti-arrhythmic agent (one that interferes directly with the depolarization of the cardiac membrane and thus serves ... A class I anti-arrhythmic agent (one that interferes directly with the depolarization of the cardiac membrane and thus serves ... as a membrane-stabilizing agent) with a depressant action on the heart similar to that of guanidine. It also possesses some ...
Anti-Arrhythmia Agents 100% * Cardiac Arrhythmias 36% * Elderly 29% * Torsades de Pointes 28% ... Arrhythmias and women. Wolbrette, D. & Patel, H., Mar 18 1999, In: Current Opinion in Cardiology. 14, 1, p. 36-43 8 p.. ... Treatment of arrhythmias during pregnancy. Wolbrette, D., Apr 1 2003, In: Current womens health reports. 3, 2, p. 135-139 5 p. ... Gender differences in arrhythmias. Wolbrette, D., Naccarelli, G., Curtis, A., Lehmann, M. & Kadish, A., 2002, In: Clinical ...
Anti-Arrhythmia Agents - pharmacology. en_HK. dc.subject.mesh. Atrial Fibrillation - physiopathology - therapy. en_HK. ...
Anti-Arrhythmia Agents Medicine & Life Sciences 14% * AZD 7009 Medicine & Life Sciences 14% ... ECG Modeling for Simulation of Arrhythmias in Time-Varying Conditions. Bachi, L., Halvaei, H., Perez, C., Martin-Yebra, A., ... Prognostic Implications of Supraventricular Arrhythmias. Hygrell, T., Stridh, M., Friberg, L. & Svennberg, E., 2021, In: ... He is founder of the company Cardiolund AB which is focused on automated ECG analysis for arrhythmia screening and patient ...
Anti-Arrhythmia Agents/adverse effects (1) * Anti-Arrhythmia Agents/therapeutic use (1) ...
Anti-Arrhythmia Agents Medicine & Life Sciences 17% * Angiotensin Receptor Antagonists Medicine & Life Sciences 17% ...
Acidifying Agents. Class Summary. Consequences of severe metabolic alkalosis include increased susceptibility to ventricular ... It may also be indicated if rapid correction of severe metabolic alkalosis is warranted (eg, in cardiac arrhythmia, hepatic ... Nonsteroidal Anti-inflammatory Drugs. Class Summary. NSIADs have analgesic, anti-inflammatory, and antipyretic activities. ... This agent acts by inhibiting inflammatory reactions and pain via decreasing the activity of cyclooxygenase, which results in a ...
Adolescent; Adult; Alleles; Anti-Arrhythmia Agents; Child; Child, Preschool; Cytochrome P-450 CYP2D6; Genetic Variation; ... Alleles; Anti-Arrhythmia Agents; Cytochrome P-450 CYP2D6; Genetic Variation; Genotype; Long QT Syndrome; Propafenone ...
PSYCHOSTIMULANTS, AGENTS USED FOR ADHD AND NOOTROPICS. Other psychostimulants and nootropics. MeSH PA. D000889. Anti-Arrhythmia ...
Anti-Arrhythmia Agents.. *Anti-Bacterial Agents.. *Digitalis Glycosides.. *Nitrites.. *Purines.. *Ajmaline.. Which drug is used ... resulting in failure to detect arrhythmia or misinterpretation of EMI as a shockable arrhythmia. ... Do not apply TENS therapy to the chest if you have heart disease, heart failure or arrhythmias. ...
Anti-Arrhythmia Agents 50% * Attention Bias Modification Treatment Versus a Selective Serotonin Reuptake Inhibitor Or Waiting ... Association of Antibiotic Use with Durability of Biologic Agents in Inflammatory Bowel Disease: a Report from the epi-IIRN. ...
Anti-Arrhythmia Agents 63% * Reperfusion 57% * Cardiac Arrhythmias 55% * Ischemia 49% 59 Scopus citations ... Mitochondrial KATP channel inhibition blunts arrhythmia protection in ischemic exercised hearts. Quindry, J. C., Schreiber, L. ...